Photodermatoses in Childhood
Nikolay N. Murashkin,
Eduard T. Ambarchian,
Roman V. Epishev,
Alexander I. Materikin,
Leonid A. Opryatin,
Roman A. Ivanov,
Daria S. Kukoleva https://doi.org/10.15690/vsp.v20i5.2308
Abstract
Photodermatoses is a heterogeneous group of diseases resulting from abnormal skin hypersensitivity to sunlight and presented as local or generalized rashes. Specific sensitivity of children's skin to ultraviolet is often the first sign or clinical symptom of photodermatosis. Abnormal photosensitivity can be represented by diverse group of primary idiopathic conditions or photo-mediated aggravation of existing dermatosis. Number of genetic genodermatoses, metabolic disorders and connective tissue diseases is also widely known. These conditions can manifest with photosensitivity associated to other extracutaneous clinical and laboratory features. Timely diagnosis of photosensitivity in childhood allows to minimize long-term complications associated with insufficient photoprotection.
Keywords
autoimmune photodermatoses,
photoaggravated dermatoses,
metabolic photodermatoses,
genetic photodermatoses
Supporting agencies: The article has been funded by LEO Pharma.
About the Authors
Nikolay N. Murashkin
National Medical Research Center of Children's Health; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical Academy
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
Nikolay N. Murashkin — receiving research grants from pharmaceutical companies Janssen, Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma plc. Scientific consultant of Galderma, Pierre Fabre, Bayer, LEO Pharma, Pfizer, AbbVie.
Eduard T. Ambarchian
Research Institute of Pediatrics and Children's Health in “Central Clinical Hospital of the Russian Academy of Sciences”
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
Eduard T. Ambarchyan — receiving research grants from pharmaceutical companies Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma plc, scientific consultant of Johnson & Johnson.
Roman V. Epishev
National Medical Research Center of Children's Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
Roman V. Epishev — receiving research grants from pharmaceutical companies Eli Lilly, Novartis.
Alexander I. Materikin
National Medical Research Center of Children's Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
Alexander I. Materikin — receiving research grants from pharmaceutical companies Eli Lilly, Novartis.
Leonid A. Opryatin
National Medical Research Center of Children's Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
No conflict of interests.
Roman A. Ivanov
National Medical Research Center of Children's Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
No conflict of interests.
Daria S. Kukoleva
National Medical Research Center of Children's Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow.
Disclosure of interest:
No conflict of interests.
References
1. Chantorn R, Lim HW, Shwayder TA. Photosensitivity disorders in children: part I. J Am Acad Dermatol. 2012;67(6):1093.e1-e18; quiz 1111-1112. doi: 10.1016/j.jaad.2012.07.033
2. Mang R., Krutmann J. Mechanisms of phototoxic and photoallergic reactions. In: Textbook of contact dermatitis. Rycroft RJG, Menne T, Frosch PJ, Lepoittevin J-P, eds. 3rd ed. Berlin: Springer; 2001. pp. 134-143.
3. Grossberg AL. Update on pediatric photosensitivity disorders. Curr Opin Pediatr. 2013;25(4):474-479. doi: 10.1097/mop.0b013e328362c2c3
4. Pacha O, Hebert AA. Pediatric Photosensitivity Disorders. Dermatol Clin. 2013;31(2):317-326. doi: 10.1016/j.det.2012.12.008
5. Jansen CT. Photosensitivity in childhood. Acta Derm Venereol Suppl (Stockh). 1981;95:54-57.
6. Horkay I, Emri G, Varga V, et al. Photosensitivity skin disorders in childhood. Photodermatol Photoimmunol Photomed. 2008;24(2):56-60. doi: 10.1111/j.1600-0781.2008.00341.x
7. Lim HW, Hawk J. Evaluation of the photosensitive patient. In: Photodermatology. Lim HW, Honigsmann H, Hawk J, eds. New York: Informa Healthcare USA; 2007. pp. 139-148.
8. Guarrera M. Polymorphous Light Eruption. Adv Exp Med Biol. 2017;996:61-70. doi: 10.1007/978-3-319-56017-5_6
9. Norris PG, Morris J, McGibbon DM, et al. Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol. 1989;120(2):173-183. doi: 10.1111/j.1365-2133.1989.tb07781.x
10. Das S, Lloyd JJ, Walshaw D, Farr PM. Provocation testing in polymorphic light eruption using fluorescent ultraviolet (UV) A and UVB lamps. Br J Dermatol. 2004;151(5):1066-1070. doi: 10.1111/j.1365-2133.2004.06235.x
11. Lembo S, Raimondo A. Polymorphic Light Eruption: What's New in Pathogenesis and Management. Front Med (Lausanne). 2018;5:252. doi: 10.3389/fmed.2018.00252
12. Tan E, Eberhart-Phillips J, Sharples K. Juvenile spring eruption: a prevalence study. N Z Med J. 1996;109(1027):293-295.
13. Stratigos AJ, Antoniou C, Papadakis P, et al. Juvenile spring eruption: clinicopathologic features and phototesting results in 4 cases. J Am Acad Dermatol. 2004;50(2 Suppl):S57-S60. doi: 10.1016/s0190-9622(03)02469-1
14. Pile HD, Crane JS. Actinic Prurigo. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available online: https://www.ncbi.nlm.nih.gov/books/NBK499957/. Accessed on October 25, 2021.
15. Valbuena MC, Muvdi S, Lim HW. Actinic Prurigo. Dermatol Clin. 2014;32(3):335-344. doi: 10.1016/j.det.2014.03.010
16. Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2002;43:128-132.
17. Cuevas-Gonzalez JC, Vega-Memnje ME, Borges-Yanez SA, Rodnguez-Lobato E. Risk factors associated with actinic prurigo: a case control study. An Bras Dermatol. 2017;92(6):774-778. doi: 10.1590/abd1806-4841.20175105
18. Pardo-Zamudio AC, Valbuena MC, Jiménez-Torres HD, Colmenares-Mejía CC. Actinic prurigo in a dermatological reference center in Colombia: 108 cases. Prurigo actínico en un centro dermatológico de referencia en Colombia: 108 casos. Biomedica. 2020;40(3):487–497. doi: 10.7705/biomedica.5139
19. Grabczynska SA, McGregor JM, Kondeatis E, et al. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1*0407. Br J Dermatol. 1999;140(2):232-236. doi: 10.1046/j.1365-2133.1999.02654.x
20. Paek SY, Lim HW. Chronic actinic dermatitis. Dermatol Clin. 2014;32(3):355-361, viii-ix. doi: 10.1016/j.det.2014.03.007
21. Huang CM, Asai Y. Chronic actinic dermatitis. CMAJ. 2018;190(10):E297. doi: 10.1503/cmaj.171111
22. Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther. 2003;16(1):45-51. doi: 10.1046/j.1529-8019.2003.01607.x
23. Haddad JM, Monroe HR, Hardin J, et al. Hydroa vacciniforme: a rare photodermatosis. Dermatol Online J. 2014;20(8):13030/qt7961b22b.
24. Ott H, Baron JM. Nichthereditare Photodermatosen im Kindesalter. Hautarzt. 2006;57(12):1059-1066. doi: 10.1007/s00105-006-1255-z
25. Ahad T, Rhodes LE. Images in paediatrics: Haemorrhagic vesicles and varioliform scarring: consider photosensitivity. Arch Dis Child. 2020;105(3):302-303. doi: 10.1136/archdischild-2018-316272
26. Goetze S, Elsner P. Solar urticaria. J Dtsch Dermatol Ges. 2015;13(12):1250-1253. doi: 10.1111/ddg.12809
27. Fityan A, McGibbon D, Fassihi H, Sarkany RS. Paediatric solar urticaria: a case series. Br J Dermatol. 2018;178(6):1453-1454. doi: 10.1111/bjd.16325
28. Raigosa M, Toro Y, Sanchez J. Solar urticaria. Case report and literature review. Rev Alerg Mex. 2017;64(3):371-375. doi: 10.29262/ram.v64i3.202
29. Holzle E. Lichturtikaria. In: Holzle E: Photodermatosen und Lichtreaktionen der Haut. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2003. pp. 130-153.
30. Harris BW, Badri T, Schlessinger J. Solar Urticaria. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available online: https://www.ncbi.nlm.nih.gov/books/NBK441986. Accessed on October 25, 2021.
31. Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol. 2008;59:909-920; quiz 921-922. doi: 10.1016/j.jaad.2008.08.020
32. Khlebnikova AN. Current approaches to the external therapy of photodermatoses. Vestnik Dermatologii i Venerologii. 2011;(4):88-95. (In Russ).
33. Lim HW. Abnormal responses to ultraviolet radiation: photosensitivity induced by exogenous agents. In: Fitzpatrick's dermatology in general medicine. Goldsmith LA, Katz SL, Gilchrest BA, et al, eds. 8th ed. New York: McGraw-Hill; 2012. pp. 1066-1074.
34. O'Gorman SM, Murphy GM. Photoaggravated disorders. Dermatol Clin. 2014;32(3):385-398, ix. doi: 10.1016/j.det.2014.03.008
35. Oakley AM, Badri T, Harris BW. Photosensitivity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available online: https://www.ncbi.nlm.nih.gov/books/NBK431072. Accessed on October 25, 2021.
36. Askanase A, Shum K, Mitnick H. Systemic lupus erythematosus: an overview. Soc Work Health Care. 2012;51(7):576-586. doi: 10.1080/00981389.2012.683369
37. Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146(1):26-30. doi: 10.1001/archdermatol.2009.328
38. Strowd LC, Jorizzo JL. Review of dermatomyositis: establishing the diagnosis and treatment algorithm. J Dermatolog Treat. 2013;24(6):418-421. doi: 10.3109/09546634.2012.697540
39. Alsharif SH, Alesa D, Baabdullah A. Type 1 Segmental Darier Disease: Case Report and Discussion of the Treatment Options. Case Rep Dermatol. 2020;12(3):159-167. doi: 10.1159/000509177
40. Naji Rad S, Vashisht P. Malar Rash. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available online: https://www.ncbi.nlm.nih.gov/books/NBK555981. Accessed on October 25, 2021.
41. Wolf P, Weger W, Patra V, et al. Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference? Exp Dermatol. 2016;25(12):937-944. doi: 10.1111/exd.13137
42. Napolitano M, Monfrecola G, Fabbrocini G, et al. Impact of sun exposure on adult patients affected by atopic dermatitis. G Ital Dermatol Venereol. 2020. doi: 10.23736/S0392-0488.20.06582-7
43. Balwani M. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management. Mol Genet Metab. 2019;128(3):298-303. doi: 10.1016/j.ymgme.2019.01.020
44. Gouya L, Martin-Schmitt C, Robreau AM, et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet. 2006;78(1):2-14. doi: 10.1086/498620
45. Horner ME, Alikhan A, Tintle S, et al. Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology. Int J Dermatol. 2013;52(12):1464-1480. doi: 10.1111/ijd.12305
46. Gadzhimuradov MN, Alieva MG, Mamasheva GD, Gadzhimuradova KM. Xeroderma pigmentosa. Russian Journal of Clinical Dermatology and Venereology = Klinicheskaya der-matologiya i venerologiya. 2019;18(4):442-447. (In Russ). doi: 10.17116/klinderma201918041442
47. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123(2):241-250. doi: 10.1001/archderm.123.2.241
48. Black JO. Xeroderma Pigmentosum. Head Neck Pathol. 2016;10(2):139-144. doi: 10.1007/s12105-016-0707-8
49. Soffer D, Grotsky HW, Rapin I, Suzuki K. Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann Neurol. 1979;6:340-348. doi: 10.1002/ana.410060407
50. Liang C, Kraemer KH, Morris A, et al. Characterization of tiger-tail banding and hair shaft abnormalities in trichothiodystrophy. J Am Acad Dermatol. 2005;52:224-232. doi: 10.1016/j.jaad.2004.09.013
51. Ferrando J, Mir-Bonafe JM, Cepeda-Valdes R, et al. Further insights in trichothiodistrophy: a clinical, microscopic, and ultrastructural study of 20 cases and literature review. Int J Trichology. 2012;4(3):158-163. doi: 10.4103/0974-7753.100075
52. Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol. 2001;44:891-920; quiz 921-924. doi: 10.1067/mjd.2001.114294
53. Pesce K, Rothe MJ. The premature aging syndromes. Clin Dermatol. 1996;14(2):161-170. doi: 10.1016/0738-081x(95)00151-5
54. Kaneko H, Kondo N. Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. Expert Rev Mol Diagn. 2004;4(3):393-401. doi: 10.1586/14737159.4.3.393
55. German JC. Bloom's syndrome. Dermatol Clin. 1995;13(1):7-18.
56. German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore). 1993;72(6):393-406.
57. Guerrero-Gonzalez GA, Marti'nez-Cabriales SA, Hernandez-Juarez AA, et al. Rothmund-thomson syndrome: a 13-year follow-up. Case Rep Dermatol. 2014;6(2):176-179. doi: 10.1159/000365625
58. Wang LL, Plon SE. Rothmund-Thomson Syndrome. In: GeneReviews® [Internet]. Adam MP, Ardinger HH, Pagon RA, et al., eds. Seattle (WA): University of Washington, Seattle; 1993-2021.
59. Witsch-Baumgartner M, Fitzky BU, Ogorelkova M, et al. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet. 2000;66(2):402-412. doi: 10.1086/302760
60. DeBarber AE, Eroglu Y, Merkens LS, et al. Smith-Lemli-Opitz syndrome. Expert Rev Mol Med. 2011;13:e24. doi: 10.1017/S146239941100189X
61. Tierney E, Nwokoro NA, Porter FD, et al. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet. 2001;98(2):191-200. doi: 10.1002/1096-8628(20010115)98:2<191::aid-ajmg1030>3.0.co;2-m
62. Yashar SS, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther. 2003;16(1):1-7. doi: 10.1046/j.1529-8019.2003.01601.x
63. Kim JJ, Lim HW. Evaluation of the photosensitive patient. Semin Cutan Med Surg. 1999;18(4):253-256. doi: 10.1016/s1085-5629(99)80024-8
64. Lehmann P. Diagnostic approach to photodermatoses. J Dtsch Dermatol Ges. 2006;4(11):965-975. doi: 10.1111/j.1610-0387.2006.06010.x
65. Aravijskaya ER, Sokolovsky EV. Photoprotection in contemporary dermatology and cosmetology: traditional issues and new data. Vestnik Dermatologii i Venerologii. 2013;(3):114-118. (In Russ).
66. American Academy of Ophthalmology. Sunglasses. Available online: http://www.aao.org/eyecare/tmp/Sunglasses.cfm. Accessed on November 11, 2012.
67. Luger T. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol. 2011;25(3):251-258. doi: 10.1111/j.1468-3083.2010.03789.x
68. Kecskes A, Heger-Mahn D, Kuhlmann RK, Lange L. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity. J Am Acad Dermatol. 1993;29(4):576-580. doi: 10.1016/0190-9622(93)70224-h
Review
For citations:
Murashkin N.N., Ambarchian E.T., Epishev R.V., Materikin A.I., Opryatin L.A., Ivanov R.A., Kukoleva D.S. Photodermatoses in Childhood. Current Pediatrics. 2021;20(5):360-369. (In Russ.) https://doi.org/10.15690/vsp.v20i5.2308
Views:
3083
Email this article 
